BIA: Three new faces on the boardThe BIA has added three new members to the Board of Directors. Calchan CEO Brenda Reynolds (pictured), Immunocore Chief Business Officer Eva-Lotta Allan and Polar Capital’s Partner – Healthcare Dan Mahony … more ➔
Ayoxxa: Bridging the gapCologne-based biotech Ayoxxa Biosystems GmbH announces that Rodney Turner has assumed duties as the interim CEO. Prior CEO Andreas Schmidt has stepped down. more ➔
Merus: Changes in managementDutch immuno-oncology company Merus has appointed John Crowley its Chief Financial Officer. Former CFO Shelley Margetson has been elevated to Chief Operating Officer. more ➔
TxCell: Cell engineering virtuosoFrench cellular immunotherapy company TxCell has hired ex-Novartis Lab Head Li Zhou to lead its CAR-Treg programmes. Zhou was appointed Vice President Cell Engineering in October. more ➔
Targovax: CFO turned CEONorwegion immuno-oncology play Targovax has promoted Øystein Soug, previously the company’s Chief Financial Officer, to the role of Chief Executive Officer. He succeeds Gunnar Gårdemyr, who has stepped … more ➔
Stora Enso: Consumer Board leaderFinnish-Swedish biomaterial expert Stora Enso has appointed Annica Bresky as Executive Vice President, Consumer Board division and member of the Group Leadership Team. Bresky joins from Iggesund Paperboard … more ➔
Icon plc: Rising through the ranksIrish drug developer Icon plc has announced that, come March 2017, Steve Cutler will take over the leadership of the company. He succeeds Ciaran Murray, who will in turn transition to the role of Chairman … more ➔
BIST: Distinguished directorMiquel A. Pericàs has taken over as general director of the Barcelona Institute of Science and Technology (BIST). The chemical engineer has been holding the position of director of the Institute of … more ➔
3P Biopharmaceuticals: Business Developer3P Biopharmaceuticals has hired Andrew Carver as its new Senior Head of Business Development. Carver joins 3P from UK-based CDMO Fujifilm Diosynth Biotechnology. more ➔
EffRx Pharmaceuticals: Filling a vacancyAfter being leaderless for over a year, EffRx has a new CEO. In October, EffRx announced that Lorenzo Bosisio has taken over the company’s helm in July. more ➔
